Tami Tillotson Martin, VP of Regulatory Affairs at SUPERNUS PHARMACEUTICALS INC (SUPN), bought 2,500 shares at $5.00 ($13K) on 2012-05-04, disclosed to the SEC on 2012-05-07.
Open-market purchase of $12k SUPN by VP of Regulatory Affairs. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| Filing → |
| SUPN | SELL | 2023-08-29 | $324K | — | Filing → |
| SUPN | SELL | 2022-08-23 | $360K | — | Filing → |
| SUPN | SELL | 2022-08-05 | $330K | — | Filing → |